Saturday, July 4, 2020
Home Biotech News 2020 Watch List

2020 Watch List

    Latest
    Immunomedics, Biotech Stock Review

    Immunomedics (IMMU) $33 | Raising Price Potential to $60. American BriVision (ABVC) $3.00 |...

    Biotech News Editor / Curator -
    We Are Raising the Price Potential of Immunomedics (IMMU) to $60, Highest on the Street, and Initiating Coverage on Another $3.00 Medical...

    Update: Biotech 5 Pack. 5 Biotech Stocks, we Expected to Double in 2020.

    Biotech News Editor / Curator -
    No Doubles Yet, But They're Doing Rather Well, Considering Everything. Our Confidence Remains Unwavered. Best Performer up 63%.
    Immunomedics IMMU, Biotech Stock Review

    Immunomedics (IMMU) up 100% Today or $2 Billion in Value.

    2020 Watch List Editor / Curator -
    Again as mentioned a few weeks ago, our bearish market opinion is related to large-caps and large-cap funds and ETF's. If...

    Latest article

    Citius (CTXR) CEO Myron Holubiak Live on TV, 1:20 Today, June 30th.

    2020 Watch List Editor / Curator -
    VIDEO: Citius CEO Myron Holubiak to Appear on TD Ameritrade Network's The Watch List with Nicole Petallides
    Citius Pharma

    Citius Pharma (CTXR) On The Move.

    2020 Watch List Editor / Curator -
    One Of Our Top 5 Biotech Picks For 2020 Up 23% Yesterday, Indicating Up Another 24% This Morning. Inquiring Minds Want...
    Biotech Stock Review

    Meet The Billion-Dollar Family Company That Makes Purell (Forbes).

    Superbug News Editor / Curator -
    Jerry and Goldie Lippman cofounded Gojo in Akron, Ohio, in 1946. Forbes 3/20/2020 Panic buying is...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: roland@institutionalanalyst.com
    © Managed by Revelers.IO Media Group Inc.